Sort Through Options for ESBL, CRE, and Resistant Pseudomonas

We're getting questions about how to treat multidrug-resistant (MDR) gram-negative infections.

These infections are often caused by extended-spectrum beta-lactamase (ESBL) producers...carbapenem-resistant Enterobacterales (CRE)...or Pseudomonas with "difficult-to-treat resistance" (DTR).

Be ready to answer questions and work with your ID team.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals